Selection of genotypes harbouring mutations in the cytochrome b gene of Theileria annulata is associated with resistance to buparvaquone.
Buparvaquone remains the only effective therapeutic agent for the treatment of tropical theileriosis caused by Theileria annulata. However, an increase in the rate of buparvaquone treatment failures has been observed in recent years, raising the possibility that resistance to this drug is associated...
Main Authors: | Selin Hacılarlıoglu, Huseyin Bilgin Bilgic, Serkan Bakırcı, Andrew Tait, William Weir, Brian Shiels, Tulin Karagenc |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0279925 |
Similar Items
-
Selection of genotypes harbouring mutations in the cytochrome b gene of Theileria annulata is associated with resistance to buparvaquone
by: Selin Hacılarlıoglu, et al.
Published: (2023-01-01) -
Identification and Analysis of Immunodominant Antigens for ELISA-Based Detection of Theileria annulata.
by: Huseyin Bilgin Bilgic, et al.
Published: (2016-01-01) -
Identification of candidate transmission-blocking antigen genes in Theileria annulata and related vector-borne apicomplexan parasites
by: Laetitia Lempereur, et al.
Published: (2017-06-01) -
Genetic characterisation of the Theileria annulata cytochrome b locus and its impact on buparvaquone resistance in bovine
by: Qasim Ali, et al.
Published: (2022-12-01) -
Sequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment Failure.
by: Moez Mhadhbi, et al.
Published: (2015-01-01)